Clinical Trial

pBFS-guided cTBS at Different Doses for Aphasia After Stroke

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2025 (before its estimated September 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this trial is to evaluate the effectiveness and safeness of different doses of continuous Theta Burst Stimulation (cTBS) over the right Superior Frontal Gyrus (SFG), guided by personalized Brain Function Sector (pBFS) technology, on language function recovery in patients with post-stroke aphasia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-23; most recent amendment 2025-04-02.
Status change: Not Yet Recruiting → Recruiting 2023-09-25
Trial Details
NCT Number NCT05969548
Lead Sponsor Changping Laboratory
Conditions Stroke, Aphasia
Enrollment 60 participants
Start Date 2023-09-22
Primary Completion 2025-09-22 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2025-04-04